STREPSILS

This brand name is authorized in Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Nigeria, Netherlands, New Zealand, Poland, Romania, Tunisia, United Kingdom, South Africa

Active ingredients

The drug STREPSILS contains a combination of these active pharmaceutical ingredients (APIs):

1 Dichlorobenzyl alcohol UNII 1NKX3648J9 - DICHLOROBENZYL ALCOHOL

Dichlorobenzyl alcohol has antiseptic properties. Read about Dichlorobenzyl alcohol

2 Amylmetacresol UNII 05W904P57F - AMYLMETACRESOL

Amylmetacresol is an antibacterial and antiviral agent, and blocks voltage-gated Na channels in a local anesthetic-like manner. It relieves symptoms of sore throat/irritation of the throat. Amylmetacresol is thought to inhibit the inflammatory and pain mediators that are involved in the inflammation of the mouth and throat mucous membranes, as well as the sore throat. Read about Amylmetacresol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STREPSILS STRAWBERRY SUGAR FREE Lozenge	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R02AA03	Dichlorobenzyl alcohol	R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AA Antiseptics
Discover more medicines within R02AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1013083, 1013106, 1744095
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 483218-7-10, 483218710IP, 56417, 56418, 61935, 76813, 76814
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 088207, 088218, 127383, 128078, 160443, 386900, 419436, 541169, 549278
Country: FR	Base de données publique des médicaments	Identifier(s): 61966199, 62009928, 65431016, 67591507, 68466734
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 122099, 122100, 147000, 216804, 357491, 37295
Country: HK	Department of Health Drug Office	Identifier(s): 19286, 19288, 51189, 54676, 59795, 60367, 61196, 62487
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3961, 3963, 5186, 5274, 5392, 5404, 5460, 5539
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1015938, 1015940
Country: MT	Medicines Authority	Identifier(s): MA1447/00201, MA1447/00202
Country: NG	Registered Drug Product Database	Identifier(s): 04-2087
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 120057
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11792, 11793, 12369, 13538, 15521, 15543, 15783, 2194, 2196
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100064020, 100064037, 100064043, 100083218, 100198683, 100340804, 100372394, 100375903, 100377150, 100385994, 100401345
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66049001, W66049002, W66077001, W66077002, W66077003, W66077004, W66079001, W66079002, W66079003, W66082001, W66082002, W66082003, W66082004, W66082005, W66092001, W66092002, W66092003, W66092004
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10673022
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/16.4/0502, A40/16.4/0358, E/16.4/46